COLL vs PCG · P/E 17, rev $181.9M vs P/E 13, $37.68B cap
Collegium Pharmaceutical Inc (COLL) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
PCG does not have a complete income-statement cache yet.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the COLL and PCG stock pages for the full models.
Not investment advice.